PRIOVANT Trademark

Trademark Overview


On Thursday, February 10, 2022, a trademark application was filed for PRIOVANT with the United States Patent and Trademark Office. The USPTO has given the PRIOVANT trademark a serial number of 97261339. The federal status of this trademark filing is REGISTERED as of Tuesday, December 13, 2022. This trademark is owned by Roivant Sciences GmbH. The PRIOVANT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for human use, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders; biological preparations for medical and therapeutic purposes, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders

Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions

Scientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceutical and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine
priovant

General Information


Serial Number97261339
Word MarkPRIOVANT
Filing DateThursday, February 10, 2022
Status700 - REGISTERED
Status DateTuesday, December 13, 2022
Registration Number6924850
Registration DateTuesday, December 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders; biological preparations for medical and therapeutic purposes, namely, for the prevention and treatment of immunological, auto-immune, rheumatological, dermatological and oncological diseases and disorders
Goods and ServicesProviding health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions
Goods and ServicesScientific and technological services, namely, medical research, scientific research and analysis in the fields of pharmaceutical and biomedicine; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePRIOVANT THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEW YORK, NY 10036

Party NameRoivant Sciences GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameRoivant Sciences GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBasel 4051
CH

Party NameRoivant Sciences GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBasel 4051
CH

Trademark Events


Event DateEvent Description
Friday, March 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 13, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 13, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 27, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 17, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 17, 2022ASSIGNED TO LIE
Wednesday, August 17, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 17, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, August 17, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, July 21, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 21, 2022FINAL REFUSAL E-MAILED
Thursday, July 21, 2022FINAL REFUSAL WRITTEN
Thursday, July 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 27, 2022NON-FINAL ACTION E-MAILED
Wednesday, April 27, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 27, 2022ASSIGNED TO EXAMINER
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 14, 2022NEW APPLICATION ENTERED